When Haemopoiesis Goes Wrong... In Other Ways Flashcards

1
Q

What are myeloproliferative disorders?

A
  • Now classified by WHO as Myeloproliferative neoplasms (MPN)
  • Essential Thrombocythaemia
  • Polycythaemia Vera
  • Myelofibrosis
  • Chronic Myeloid Leukaemia

All of these disorders involve dysregulation at the multipotent haematopoietic stem cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the clinical features of myeloprolifertaive disorders?

A
  • Overproduction of one or several blood elements with dominance of a transformed clone.
  • Hypercellular marrow / marrow fibrosis - extra deposition of fibrosis in bone marrow
  • Cytogenetic abnormalities.
  • MOst have thrombotic and/or haemorrhagic diatheses.
  • All have extramedullary haemopoiesis (liver/spleen).
  • All have potential to transform to acute leukaemia.
  • Overlapping clinical features.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What mutation is common in myeloprolifrative disorders?

A

Many patients have a specific point mutation in one copy of the Janus kinase 2 gene (JAK2)
- a cytoplasmic tyrosine kinase on chromosome 9, which causes increased proliferation and survival of haematopoietic precursors We now have specific drugs targeting the aberrant protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is polycythaemia Vera?

A

• Diagnostic criteria = High haematocrit (>0.52 in men, >0.48 in
women) OR raised red cell mass
• JAK2 V617F mutation is present in approximately 95% PRV patients
• No reactive cause found
• Some patients also have high platelets & neutrophils
• Median age 60 yrs
• Male=Female

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the clinical features of PV?

A
Clinical features:
• Significant cause of arterial thrombosis
• Venous thrombosis
• Haemorrhage into skin or GI tract
• Pruritis
• Splenic discomfort , splenomegaly
• Gout
• In some transformation to myelofibrosis or acute leukaemia
Capillaries burst
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How is PV managed?

A
  • Venesection to maintain the Hct to <0.45 - remove blood
  • Aspirin 75 mg unless contraindicated - to reduce risk of thrombosis
  • Manage CVS risk factors
  • Sometimes drugs to reduce the overproduction of cells should be considered
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What needs to be considered if high Hb or haematocrit is noted?

A

Need to consider why
Is this polycythaemia vera or… Is there another explanation?
What else could cause an excess of red cells to be formed?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is polycythaemia?

A

• Polycythaemia= an increase in circulating red cell
concentration typified by a persistently raised haematocrit (Hct).

This increase can be;
Relative = normal red cell mass with decreased plasma volume or
Absolute = increased red cell mass
- primary - polycythemia vera - abnormality originates in bone marrow
- Secondary –driven by erythropoietin EPO production - either a physiological response to hypoxia or abnormal production

Check if on diuretics - these can dehydrate
If it is absolute, need to work out if primary or secondary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the classes of secondary polycythemia?

A

Physiologically appropriate EOP production - in response to tissue hypoxia
Pathological EPO production
Other causes of EPO in blood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the causes or each of the classes of secondary polycythemia?

A

Central Hypoxia – Chronic lung disease R to L shunts Training at altitude CO poisoning - red cell mass increases
Renal Hypoxia – Renal artery stenosis Polycystic disease

Hepatocellular carcinoma 
Renal cell cancer 
Cerebellar haemangioblastoma
Uterine tumours
Phaeochromocytoma
..all produce ectopic EPO

Some people give thesmseves erythropoietin so that RBC mass increases so their athletic/cycling performance increases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is essential thrombocythaemia?

A

Excess platelets - overproduction of megakaryocytes (large and excess) - leads to thrombotic events

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the management of essential thrombocythaemia?

A

• Any cardiovascular risk factors should be aggressively managed
• Aspirin
• High risk patients:
• >60 years, platelet count >1500 or disease-related thrombosis/haemorrhage
• return the platelet count into the normal range with drug such as hydroxycarbomide
- difficult to selectively remove platelets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What should be done if a high platelet count is noted?

A

Ensure it is persistent rather than transient before investigating for ET
First look for and exclude reactive causes
• Infection
• Inflammation (Inflammatory bowel disease, Rh arthritis)
• Other tissue injury (e.g. surgery, trauma, burns)
• Haemorrhage
• Cancer
• Redistribution of platelets - Post-splenectomy and hyposplenism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is myelofibrosis?

A

Heavily fibrotic marrow, little space for haemopoiesis
Blood film shows red cells looking like tear drops
• clonal haemopoietic stem cell proliferation
• May be end result of PV or ET, or
• Primary disease (PMF)
• PMF starts with proliferative phase when all counts may be
high
• Then in all cases progressive pancytopeniadue to bone
marrow fibrosis and hypersplenism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe the bone marrow liver and spleeen I myelofibrosis

A

Increasing stages of collagen and then fibrotic tissue - fewer areas of normal production of blood cells
clinically myelofibrosis quite rare
spleen grows liver starts to grow - they take over with extramedullary haematopoiesis - splenomegaly and hepatomegaly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the clinical features of myelofibrosis?

A

Patients with advanced disease experience severe
constitutional symptoms – fatigue, sweats
• The consequences of massive splenomegaly - big heard spleen - discomfort and swelling of the abdomen
• pain, early satiety (stomach cant expand so get full quickly), splenic infarction
• Progressive marrow failure requiring transfusions of blood products
• Transformation to leukaemia
• Early death

17
Q

What is CML?

A

Overproduction of all stages of myeloid cells - promyelocytes, etc etc etc, neutrophils
Very high white count
Pain in the bone marrow - ribs, back, pelvis etc,
bc viscous blood can get stuck - leads to visual disturbance and tiredness as it is not circulating well

• Usually presents with very high WCC, this may be incidental
finding
• Patients may present with symptomatic splenomegaly,
hyperviscosity (sticky blood) or bone pain
• Disease of adults, v rare in children
• Blood film and marrow will show excess of all myeloid series from blast through to fully mature neutrophils

18
Q

What causes CML?

A

The Philadelphia chromosome - chromosome 22 with bcr - abl from 9 attached
BCR-abl gene switches on a receptor tyrosise kinase - bcr-abl protein which has an ATP binding site - which drives proliferation of leukaemia cells

19
Q

What is imatinib?

A

Tyrosine kinase inhibitor
Imatinib competitively binds to binding site on bcr-abl protein - substrate cannot enter kinase site - tumour cell cannot proliferate

20
Q

What is pancytopenia

A

Reduction in white cells, red cells and platelets

Recused production or
Increased removal:

21
Q

What are ways in which there can be an increased removal or blood cells

A
  • immune destruction (rare to cause pancytopenia)
    • splenic pooling (in splenomegaly)
    • haemophagocytosis = chewing up of cells in marrow (v v rare)
22
Q

Why might there be a reduced production of blood cells?

A

 B12/folate deficiency
 Bone marrow infiltration by malignancy (blood cancers of other cancers) - if there isn’t solace to make normal blood counts bc infiltrated
 Marrow fibrosis
 Radiation - precursors die
 Drugs – chemotherapy, antibiotics, anticonvulsants, psychotropic drugs, DMARDs
 Viruses – EBV, viral hepatitis ,HIV, CMV - can stop bone marrow working temporarily
 Idiopathic aplastic anaemia
 Congenital bone marrow failure eg Fanconi’s anaemia, dyskeratosis congenital – present in childhood

23
Q

What is aplastic anaemia?

A

Pancytopenia with a hypocellular bone marrow in the absence of an abnormal infiltrate and with no increase in reticulin (fibrosis)

Difficult to treat
have to be very fit to be treated
driven by t lymphocytes
problem with thymus gland
heavy immunosupression
Refractory neutropenia infection, fungal infection
Mortality is high as cure is difficult – immune treatments and bone marrow transplantation Deaths often due to neutropenic infection or bleeding

24
Q

What are the roles of platelets in haemostasis

A
 Key role in Haemostasis to facilitate
clot formation, initially via a platelet
‘plug’:
 Adhesion to damaged endothelial
wall and to vWF
 Activation – change in shape from
disc and release of granules
 Aggregation – clumping together of
more platelets to form the plug
25
Q

What are 2 types of platelet disorders

A

 Quantitative – low (thrombocytopenia)
 Qualitative – often normal number but
defective function

26
Q

Give ab overview of thrombocytopenia?

A
Can be inherited (rare) or
Acquired (common) :
  - decreased platelet production 
  - increased platelet consumption 
  - increased platelet destruction
27
Q

What are the consequences of severe thrombocytopenia?

A
 Patients generally not symptomatic until the
platelet count < 30
 Easy bruising
 Petechiae, purpura
 Mucosal bleeding
 Severe bleeding after trauma
 Intracranial haemorrhage
28
Q

Describe immune destruction of platelets

A

 Immune thrombocytopenic purpura most common
cause – autoantibodies against Glycoprotein(GP)
IIb/IIIa and GPIb/IX
 Can be secondary to autoimmune disease eg SLE
and lymphoproliferative disorders eg lymphoma,
CLL
 Treated with immunosuppression (corticosteroids
or Intravenous immunoglobulin first line)
 Platelet transfusions do not work (as the transfuse
platelets get destroyed too)

29
Q

What are disorders of platelet function

A
  • Hereditary (v rare)
  • eg Bernard Soulier syndrome, Glanzmann’s thrombasthenia
  • Acquired (common)
  • Aspirin/NSAIDS/clopidogrel - anti platelet drug
  • Uraemia
  • Hypergammaglobulinaemia eg myeloma
  • Myeloproliferative disorders